Johannes F.E. Mann

Friedrich-Alexander-Universität Erlangen-Nürnberg

Also affiliated with Universitätsklinikum Erlangen, Katholische Stiftungshochschule München, Kidney Centre

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial”.

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial

Diabetes Care(2020)10.2337/dc19-2251

N/A

5.2DataRank · unranked

174 citations

Stephen C. Bain, Johannes F.E. Mann, Michael A. Nauck, Steven E. Nissen, Stuart Pocock +7 more

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

Nephrology Dialysis Transplantation(2023)10.1093/ndt/gfad009

N/A

5.2DataRank · unranked

239 citations

Florian M.M. Baeres, George L. Bakris, Heidrun Bosch‐Traberg, Mette Gislum, Stephen Gough +9 more

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

Nature Medicine(2024)10.1038/s41591-024-03015-5

N/A

4.6DataRank · unranked

204 citations

Ildiko Lingvay, Paul Brown, John Deanfield, Kirstine Brown‐Frandsen, Steven E. Kahn +11 more

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

Diabetes Care(2020)10.2337/dc20-0279

N/A

1.9DataRank · unranked

61 citations

Robert D. Toto, Mark E. Cooper, Johannes F.E. Mann, Julio Rosenstock, Darren K. McGuire +12 more

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

New England Journal of Medicine(2016)10.1056/nejmoa1603827

N/A

1.3DataRank · unranked

7197 citations

Gilbert H. Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F.E. Mann, Michael A. Nauck +13 more

COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf022

N/A

0.532DataRank · unranked

22 citations

Jennifer B. Green, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill, Amy K. Mottl +94 more

Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf160

N/A

0.253DataRank · unranked

4 citations

Jennifer B. Green, Hiddo J.L. Heerspink, Sung Gyun Kim, Johannes F.E. Mann, Janet B. McGill +10 more

Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)

Nephrology Dialysis Transplantation(2022)10.1093/ndt/gfac198

N/A

0DataRank · unranked

160 citations

Amy K. Mottl, George L. Bakris, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill +6 more

Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial

UNC Libraries(2021)10.17615/4ena-v672

N/A

0DataRank · unranked

0 citations

Kirstine Brown Frandsen, Johannes F.E. Mann, John B. Buse, Steven E. Nissen, William M. Steinberg +9 more

KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Kidney International(2021)10.1016/j.kint.2020.11.003

N/A

0DataRank · unranked

1403 citations

Tara I. Chang, William C. Cushman, Susan L. Furth, Fan Fan Hou, Joachim H. Ix +8 more

Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6

Nephrology Dialysis Transplantation(2024)10.1093/ndt/gfae150

N/A

0DataRank · unranked

18 citations

David Z.I. Cherney, Anja Birk Kuhlman, Johannes F.E. Mann, Søren Rasmussen, Peter Rossing +4 more

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

UNC Libraries(2020)10.17615/5vsp-zn15

N/A

0DataRank · unranked

15 citations

Peter Lommer Kristensen, Lasse Steen Ravn, Richard M. Bergenstal, Stuart Pocock, Neil R. Poulter +10 more

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Kidney International(2020)10.1016/j.kint.2020.07.013

N/A

0DataRank · unranked

119 citations

Rajiv Agarwal, William G. Herrington, Hiddo J.L. Heerspink, Johannes F.E. Mann, Shahnaz Shahinfar +76 more